- Dual Targeted Nanoparticles Encapsulating Cantharidin for Treatment of Hepatocellular Carcinoma and Lymphatic Metastasis
Wenwen Jiao et al, 2024, ACS Applied Nano Materials CrossRef - Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging
Stefanie J. Hectors et al, 2017, Scientific Reports CrossRef - Identification of miRNA-mRNA associations in hepatocellular carcinoma using hierarchical integrative model
Rency S. Varghese et al, 2020, BMC Medical Genomics CrossRef - LC‐MS/MS‐based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma
Tsung‐Heng Tsai et al, 2015, PROTEOMICS CrossRef - The prognostic influence of lymphatic endothelium–specific hyaluronan receptor 1 in cancer: A systematic review
Sini Karinen et al, 2022, Cancer Science CrossRef - Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca et al, 2023, Clinical and Molecular Hepatology CrossRef - Update June 2014
Francine Blei, 2014, Lymphatic Research and Biology CrossRef - Hyaluronic acid as a tumor progression agent and a potential chemotherapeutic biomolecule against cancer: A review on its dual role
Simran Gagneja et al, 2024, International Journal of Biological Macromolecules CrossRef - Multifaceted roles of lymphatic and blood endothelial cells in the tumor microenvironment of hepatocellular carcinoma: A comprehensive review
Jing-Jing Li et al, 2024, World Journal of Hepatology CrossRef - The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis
Masatake Tanaka et al, 2016, Cellular and Molecular Gastroenterology and Hepatology CrossRef - A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
Hui Hu et al, 2022, Cells CrossRef - hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492
Zhenzhen Feng et al, 2023, Disease Markers CrossRef